OPRX - OptimizeRx raises 2025 revenue guidance to $101M-$106M as subscription transition gains traction
2025-05-12 21:57:01 ET
More on OptimizeRx
- OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript
- OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript
- OptimizeRx Q1 2025 Earnings Preview
- OptimizeRx beats top-line and bottom-line estimates; initiates FY25 outlook
- Seeking Alpha’s Quant Rating on OptimizeRx